Skip to content
FrontierPicks

Dossier · EPAM · Dormant

EPAM · EPAM SYSTEMS, INC. · Stock research

Last analysed ·

Resolved Graded and closed 2026-08-21 at low conviction — the published kill line did not fire. Coverage continued after the close; the read below is dated 2026-08-23 and is not part of the scored record.

Current thesis

Compounder narrative broken on 2026-08-06: FY26 organic constant-currency growth cut to 2.0%–3.0%, Q3 guided to ~1.7% YoY. Price has stalled rather than extended lower ($99.90 close 2026-08-11 vs $97.43 on 2026-08-07), but the AI-native replacement ($160M in Q2, >11% of revenue) gets no dated proof until the ~November Q3 print.

Kill line

A weekly close below $92 confirms the post-guidance-cut de-rating leg resumed and puts the $73.06 52-week low back in play; secondarily, a Q3 report around 2026-11-05 guiding Q4 organic constant-currency growth below zero would end the stabilisation case.

Pick status

Played out resolved published kill line did not fire How this is scored →

Latest analysis and events for EPAM —

As of 23 August 2026, the latest FrontierPicks analysis for EPAM SYSTEMS, INC. (EPAM): Compounder narrative broken on 2026-08-06: FY26 organic constant-currency growth cut to 2.0%–3.0%, Q3 guided to ~1.7% YoY. Price has stalled rather than extended lower ($99.90 close 2026-08-11 vs $97.43 on 2026-08-07), but the AI-native replacement ($160M in Q2, >11% of revenue) gets no dated proof until the ~November Q3 print.

Kill line: A weekly close below $92 confirms the post-guidance-cut de-rating leg resumed and puts the $73.06 52-week low back in play; secondarily, a Q3 report around 2026-11-05 guiding Q4 organic constant-currency growth below zero would end the stabilisation case.

Current Thesis

The leg an investor was buying in EPAM — a digital-engineering compounder that turns AI into a larger book of billable work — was repriced on 2026-08-06, when Q2 revenue of $1.415B (+4.5% YoY, +3.4% organic constant currency) and non-GAAP diluted EPS of $3.38 (+22.0% YoY versus a $3.14 estimate) both cleared consensus and the company still cut FY2026 revenue guidance to $5.632B–$5.686B from $5.675B–$5.813B. Organic constant-currency growth went to 2.0%–3.0%; Q3 was guided to $1.410B–$1.425B against $1.445B consensus, roughly 1.7% YoY at the midpoint. CEO Fejes described clients moving budget out of task-based work faster than AI-led replacement work ramps, "creating a growth gap."

What has changed since the 2026-08-12 update is entirely price. The stock closed $97.43 on 2026-08-07, $99.90 on 2026-08-11, $107.43 on 2026-08-19 (market capitalisation $5.58B, per ad-hoc-news 2026-08-20) and $110.34 on 2026-08-21. No company disclosure, filing or guidance change landed in that span; the last dated company event remains the 2026-07-28 OpenAI Advanced Partner announcement and the 2026-08-06 print. A roughly two-week recovery off a post-cut low, unaccompanied by new information, is a re-rating of sentiment against an unchanged fact set.

The narrative is dead, and the label refers to the narrative rather than the tape. Dating it: the 2026-08-06 guidance cut, William Blair's same-day downgrade to Market Perform, and a price-target cut sequence that has run since 2026-07-09 and had not stopped as of 2026-08-10 (Mizuho $162→$130; Guggenheim $165→$140, both 2026-08-10). The replacement story is inside the numbers — AI-native revenue of $160M in Q2, above 11% of total, a sixth consecutive quarter of double-digit sequential growth against roughly a $600M annual pace — but management placed meaningful revenue from large AI-driven deals in early 2027 and declined to guide 2027. Nothing dated tests it before the Q3 report.

Bullish and bearish views on EPAM SYSTEMS, INC.

The model's bull view on EPAM SYSTEMS, INC. (EPAM), in brief: AI-native revenue $160M in Q2 2026, over 11% of total, sixth straight quarter of double-digit sequential growth (Q2 call, 2026-08-06). The bear view: The 2026-08-06 cut took FY2026 organic constant-currency growth to 2.0%–3.0%, and Q3 to about 1.7% YoY at the midpoint against $1.445B consensus. Both cases follow in full.

Bull Case

  • AI-native revenue $160M in Q2 2026, over 11% of total, sixth straight quarter of double-digit sequential growth (Q2 call, 2026-08-06). The roughly $600M annual trajectory survived the top-line cut.
  • FY2026 non-GAAP diluted EPS guidance was narrowed with the low end lifted — $12.98–$13.28 to $13.08–$13.24 against $13.04 consensus — while revenue came down (2026-08-06 release). FY2026 GAAP diluted EPS is guided $8.22–$8.38 on a GAAP operating margin of 10.5%–11.0%.
  • Margin held through the cut: Q2 non-GAAP income from operations 16.4% of revenue, GAAP 10.8% (2026-08-06 release).
  • Financial Services grew 11.5% YoY and Life Sciences & Healthcare 8% YoY in Q2 2026 (Q2 call).
  • Share count is shrinking.
  • Balance sheet funds the transition: cash and equivalents $789.4M, Q2 repurchases $85M, $409M year-to-date through 2026-06-30 (2026-08-06 release).
  • Market capitalisation of $5.58B on 2026-08-19 sits below the guided FY2026 revenue range of $5.632B–$5.686B.

Bear Case

  • The 2026-08-06 cut took FY2026 organic constant-currency growth to 2.0%–3.0%, and Q3 to about 1.7% YoY at the midpoint against $1.445B consensus. The company attributed it to substitution, not a macro pause.
  • Software & Hi-Tech contracted 1.3% YoY in Q2 2026 while Financial Services carried the quarter at +11.5% YoY (Q2 call).
  • Reported revenue growth (4.5%) exceeded organic constant-currency growth (3.4%) in Q2 2026, so FX flatters the headline line.
  • Delivery headcount grew — 62,850 total, 56,650 delivery professionals, +1.5% YoY — against a guided low-single-digit revenue trajectory. Inferred, not disclosed: that combination puts utilisation and pricing on the burden of proof at the Q3 print.
  • The 2026-08-19 close of $107.43 is above Citigroup's $100 target (2026-07-27), Morgan Stanley's $100 (2026-08-04) and Truist's $110 (2026-08-07, cut from $112). Simply Wall St reported the consensus target fell 8.2% to $124 after the Q2 result.
  • The recovery has carried price back toward the levels that produced the July target cuts, without any revision to the guidance those cuts were responding to.

Setup & Price Structure

  • Reference point: the 2026-08-21 close of $110.34, 50.2% below the $221.4 52-week high, with RSI(14) at 53.2 and a three-month price change of +7.4%.
  • The post-print structure is a shelf. The 2026-08-11 session ranged $96.53–$100.70 and closed $99.90 (+2.60%); the low close since the cut is $97.43 on 2026-08-07. Price has since travelled to $107.43 (2026-08-19) and $110.34 (2026-08-21) without revisiting it.
  • RSI at 53.2 after that run is mid-range — the advance has not stretched momentum to an extreme, which cuts both ways: no exhaustion signal, and no confirmation that a trend has established.
  • Positioning observables, stated as observables: no earnings date inside 30 days; a completed buyback program, so the documented repurchase flow that ran at $85M in Q2 has no disclosed continuation until the Q3 10-Q; and a target panel that disagrees with itself — public.com shows a 17-analyst average of $133.94 with a $225 high and an $83 low, Simply Wall St quotes $124, and ad-hoc-news quoted a $116.47 consensus alongside a $113.38 third-party fair-value estimate (all as retrieved 2026-08-23).
  • No insider transactions appear in the filings reviewed for the period since the print.

Catalyst Calendar (next 30 days)

  • ~2026-09-25 (est.) — Accenture FY Q4 results and FY2027 outlook. Just outside the window; the nearest dated read-across on whether agentic delivery is compressing billable-hour work across IT services broadly.
  • 2026-09-30 — the quarter guided to $1.410B–$1.425B closes. Nothing about that guide is verifiable before this date, and the disclosure arrives a month later.
  • ~2026-10-29 (est.) — Q3 2026 results and Q4 guidance, per third-party earnings calendars; EPAM had not published a scheduling release as of 2026-08-23 in the material reviewed, and prior-year cadence spans late October to early November.
  • ~2027-02 (est.) — Q4/FY2026 results with initial FY2027 guidance, where management's claim about large AI-driven deals ramping in early 2027 becomes a number.

Elapsed catalysts

  • No company-dated event falls inside 30 days of 2026-08-23. The window is empty by the company's own calendar. (passed 3d ago)

What Would Change Our Mind

The structure that matters is the $96.53–$100.70 post-cut shelf the August recovery left behind. Give it back and the stabilisation reading is finished: a weekly close below $99 retraces the entire post-guidance-cut bounce and returns the $73.06 52-week low to the frame. On the fundamental side, the substitution thesis stops being an interpretation and becomes a trend if the Q3 report (~2026-10-29 est.) guides Q4 organic constant-currency growth below zero, if the AI-native sequential streak breaks after six quarters, or if Financial Services decelerates out of double-digit YoY growth.

Running the other way: two consecutive weekly closes above $110.70 with the Q3 print confirming AI-native revenue tracking past the roughly $600M annual pace would make the replacement narrative dated evidence rather than management assertion. A successor repurchase authorisation disclosed with the Q3 10-Q would restore a documented bid that currently has no stated continuation.

Correlation Notes

  • EPAM trades inside the IT-services complex (ACN, CTSH, INFY, WIT, GLOB) and moves with it on days when the whole group re-rates; the 2026-08-19 advance was reported as occurring alongside a sector-wide rally (AlphaStreet), which argues part of the recovery is group beta rather than name-specific.
  • The name is the negative-facing leg of the AI-labour trade: the same agentic-delivery story that supports AI infrastructure spending is the mechanism management cited for its own growth gap. Correlation to AI-infrastructure winners can be inverse on narrative days.
  • FX is a live second-order driver — reported growth of 4.5% against 3.4% organic constant currency in Q2 2026 means a weaker dollar flatters the print and a stronger one compounds the guided deceleration.
  • Accenture's late-September fiscal Q4 is the closest scheduled peer disclosure and will generalise or narrow the substitution mechanism before EPAM reports.

Notes

  • EPAM reports on a calendar fiscal year. As of 2026-08-23 the company had not published a Q3 2026 scheduling release; third-party calendars show ~2026-10-29.
  • GAAP and non-GAAP guidance diverge widely (FY2026: $8.22-$8.38 GAAP vs $13.08-$13.24 non-GAAP diluted EPS) - check which measure a headline quotes.
  • No dividend. Capital return runs entirely through repurchases: $85M in Q2 2026 and $409M year-to-date through 2026-06-30.
  • The $632.49M repurchase program completed in early August 2026 sat under a $1B board authorisation reported as announced 2025-10-21; remaining capacity becomes a filed number in the Q3 10-Q.
  • Reported revenue growth exceeded organic constant-currency growth in Q2 2026 (4.5% vs 3.4%), so FX flatters the headline revenue line.
  • Consensus price-target vendors disagree materially - $116.47, $124 and $133.94 were all quoted as of 2026-08-23. Check the panel size before citing one.

Related · shared themes

HUM

Humana Inc.

Margin-over-volume Medicare Advantage reset reclaimed its trend: the 2026-08-24 close of $386.61 is 2.0% above the prior session and back clear of the last 50-day value observed ($378.33, 2026-08-12), with RSI(14) at 64.6 from 52.5. Revision flow idle since Bernstein's 08-14 Buy/$425, and the 2027 number now has a venue — a 2026-12-10 investor update — past both the 09-08/10 conference window and the 11-06 print. The narrative is maturing.

MEDIUM

MRCY

Mercury Systems Inc

Defense-electronics turnaround still re-rating on record bookings and a promised FCF turn, but the stock has given back ~20% from its $128.45 ATH and now chops near the analyst median (~$103) into a binary ~Aug 10-18 Q4/full-year print. Consolidation, not acceleration — the move is maturing into the report.

MEDIUM

OKTA

Okta, Inc.

Identity-security re-rating in its second, sell-side-led leg; the upgrade wave is still building nearly two months post-print — Wells Fargo lifted its target to $150 from $100 on 2026-07-20, collapsing the low-end dispersion. Cyber theme accelerating, this leg maturing; open risk is paying up for a stretched 52-week-high tape.

MEDIUM

RXO

RXO, Inc.

Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to consensus; the ~2026-08-05 Q2 print (adj EBITDA guide $27–37M vs $6M Q1) is the binary the whole re-rate discounts.

MEDIUM